This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2E Lenaghan , R Holland , A Brooks . Home-based medication review in a high risk elderly population in primary care – the POLYMED randomised controlled trial. Age Ageing 2007; 36: 292–97.
3CJ Lowe , DK Raynor , J Purvis , A Farrin , J Hudson . Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol 2000; 50: 172–75.
4DW Bates , DJ Cullen , N Laird , LA Petersen , SD Small , D Servi Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274: 29–34.
5JR Nebeker , P Barach , MH Samore . Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004; 140: 795–801.
7IR Edwards , JK Aronson . Adverse drug reactions: definitions, diagnosis and management. Lancet 2000; 356: 1255–59.
8EC Davies , CF Green , S Taylor , PR Williamson , DR Mottram , M Pirmohamed . Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE 2009; 4: e4439.
9EC Davies , CF Green , DR Mottram , M Pirmohamed . Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther 2006; 31: 335–41.
10M Pirmohamed , S James , S Meakin , C Green , AK Scott , TJ Walley Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 2004; 329: 15–19.
12JK Aronson , RE Ferner . Joining the DoTS: new approach to classifying adverse drug reactions. BMJ 2003; 327: 1222–25.
13MK Rommers , IM Teepe-Twiss , HJ Guchelaar . Preventing adverse drug events in hospital practice: an overview. Pharmacoepidemiol Drug Safety 2007; 16: 1129–35.
14LL Leape , TA Brennan , N Laird , AG Lawthers , AR Localio , BA Barnes The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. NEJM 1991; 324: 377–84.
16HJ Beijer , de CJ Blaey . Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 46–54.
17JH Gurwitz , TS Field , LR Harrold , J Rothschild , K Debellis , AC Seger Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107–16.
19M Chan , F Nicklason , JH Vial . Adverse drug events as a cause of hospital admission in the elderly. Int Med J 2001; 31: 199–205.
20J Hallas , T Haghfelt , LF Gram , E Grodum , N Damsbo . Drug related admissions to a cardiology department; frequency and avoidability. J Int Med 1990; 228: 379–84.
21G Cunningham , TRP Dodd , DJ Grant , MET McMurdo , R Michael , E Richards . Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997; 26: 375–82.
24RL Page 2nd, JM Ruscin . The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmcother 2006; 4: 297–305.
26EC Davies , CF Green , DR Mottram , M Pirmohamed . Adverse drug reactions in hospitals: a narrative review. Current Drug Safety 2007; 2: 79–87.
27LG Seidl , GF Thornton , LE Cluff . Epidemiological studies of adverse drug reactions. Am J Pub Health 1965; 55: 1170–75.
28N Hurwitz , OL Wade . Intensive hospital monitoring of adverse reactions to drugs. BMJ 1969; 1: 531–36.
29CC Smith , PM Bennett , HM Pearce , PI Harrison , DJ Reynolds , JK Aronson Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 1996; 42: 423–29.
31DJ van Kraaij , CJ Haagsma , IH Go , FW Gribnau . Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. Netherland J Med 1994; 44: 166–73.
32CM Hohl , J Dankoff , A Colacone , M Afilalo . Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001; 38: 666–71.
33CM Lindley , MP Tully , V Paramsothy , RC Tallis . Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294–300.
34CK Mannesse , FH Derkx , MA de Ridder , AJ Man in't Veld , TJ Van Der Cammen . Adverse drug reactions in elderly patients as a contributing factor for hospital admission: cross sectional study. BMJ 1997; 315: 1057–58.
35J Lazarou , BH Pomeranz , PN Corey . Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5.
36K Wester , AK Jonsson , O Spigset , H Druid , S Hagg . Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 2008; 65: 573–79.
38I Buajordet , J Ebbesen , J Erikssen , O Brors , T Hilberg . Fatal adverse drug events: the paradox of drug treatment. J Int Med 2001; 250: 327–41.
39DC Classen , SL Pestotnik , RS Evans , JF Lloyd , JP Burke . Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277: 30–36.
40DW Bates , N Spell , DJ Cullen , E Burdick , N Laird , LA Petersen The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277: 307–11.
41JM Rothschild , FA Federico , TK Gandhi , R Kaushal , DH Williams , DW Bates . Analysis of medication-related malpractice claims: causes, preventability, and costs. Arch Int Med 2002; 162: 2414–20.
42ES El Desoky . Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther 2007; 14: 488–98.
43B Tangiisuran , J Wright , T Van Der Cammen , C Rajkumar . Adverse drug reactions in elderly: challenges in identification and improving preventative strategies. Age Ageing 2009; 38: 358–59.
44AA Mangoni , SHD Jackson . Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. Br J Clin Pharmacol 2003; 57: 6–14.
46J Zeeh , D Platt . The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology 2002; 48: 121–27.
49TS Field , JH Gurwitz , J Avorn , D McCormick , S Jain , M Eckler Risk factors for adverse drug events among nursing home residents. Arch Int Med 2001; 161: 1629–34.
50JK Nguyen , MM Fouts , SE Kotabe , E Lo . Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 2006; 4: 36–41.
51LJ Veehof , RE Stewart , B Meyboom-de Jong , FM Haaijer-Ruskamp . Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 1999; 55: 533–36.
52G Onder , C Pedone , F Landi , M Cesari , Della C Vedova , R Bernabei Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). JAGS 2002; 50: 1962–68.
53Y Zopf , C Rabe , A Neubert , EG Hahn , H Dormann . Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf 2008; 31: 789–98.
54PM van den Bemt , AC Egberts , AW Lenderink , JM Verzijl , KA Simons , WS van der Pol Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci 2000; 22: 62–66.
56SE Campbell , DG Seymour , WR Primrose . A systematic literature review of factors affecting outcome in older medical patients admitted to hospital. Age Ageing 2004; 33: 110–15.
57A Kennerfalk , A Ruigomez , MA Wallander , L Wilhelmsen , S Johansson . Geriatric drug therapy and healthcare utilization in the United kingdom. Ann Pharmacother 2002; 36: 797–803.
58NS Beckett , R Peters , AE Fletcher , JA Staessen , L Liu , D Dumitrascu Treatment of hypertension in patients 80 years of age or older. NEJM 2008; 358: 1887–98.
59DN Juurlink , M Mamdani , A Kopp , A Laupacis , DA Redelmeier . Drug–drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 289: 1652–58.
60DN Juurlink , MM Mamdani , A Kopp , PA Rochon , KI Shulman , DA Redelmeier . Drug-induced lithium toxicity in the elderly: a population-based study. JAGS 2004; 52: 794–98.
61AM Holbrook , JA Pereira , R Labiris , H McDonald , JD Douketis , M Crowther Systematic overview of warfarin and its drug and food interactions. Arch Int Med 2005; 165: 1095–106.
62PA Rochon , JH Gurwitz . Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997; 315: 1096–99.
63HJ Hamilton , PF Gallagher , D O'Mahony . Inappropriate prescribing and adverse drug events in older people. BMC Geriatr 2009; 9: 5.
64ER Hajjar , JT Hanlon , RJ Sloane , CI Lindblad , CF Pieper , CM Ruby Unnecessary drug use in frail older people at hospital discharge. JAGS 2005; 53: 1518–23.
66JC McElnay , CR McCallion , F Al-Deagi , MG Scott . Development of a risk model for adverse drug events in the elderly. Clin Drug Invest 1997; 13: 47–55.
67L Bowman , BC Carlstedt , EF Hancock , CD Black . Adverse drug reaction (ADR) occurrence and evaluation in elderly inpatients. Pharmacoepidemiol Drug Safety 1996; 5: 9–18.
68BJ Vakil , RD Kulkarni , NL Chabria , DR Chadha , VA Deshpande . Intense surveillance of adverse drug reactions. An analysis of 338 patients. J Clin Pharmacol 1975; 15: 435–41.
69ER Hajjar , JT Hanlon , MB Artz , CI Lindblad , CF Pieper , RJ Sloane Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacol 2003; 1: 82–89.
70JL Green , JN Hawley , KJ Rask . Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 2007; 5: 31–39.
71H Ganjavi , N Herrmann , PA Rochon , P Sharma , M Lee , D Cassel Adverse drug events in cognitively impaired elderly patients. Dem Geriatr Cog Disord 2007; 23: 395–400.
72G Onder , G Gambassi , CJ Scales , M Cesari , CD Vedova , F Landi Adverse drug reactions and cognitive function among hospitalized older adults. Eur J Clin Pharmacol 2002; 58: 371–77.
74CK Mannesse , FH Derkx , MA de Ridder , AJ Man in't Veld , TJ Van Der Cammen . Do older hospital patients recognize adverse drug reactions? Age Ageing 2000; 29: 79–81.
75RL Howard , AJ Avery , S Slavenburg , S Royal , G Pipe , P Lucassen Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007; 63: 136–47.
76J. Reason Human error: models and management. BMJ 2000; 320: 768–70.
78LL Leape , DW Bates , DJ Cullen , J Cooper , HJ Demonaco , T Gallivan Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995; 274: 35–43.
79R Kaushal , KG Shojania , DW Bates . Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Int Med 2003; 163: 1409–16.
80DW Bates , LL Leape , DJ Cullen , N Laird , LA Petersen , JM Teich Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280: 1311–16.
81SN Kucukarslan , M Peters , M Mlynarek , DA Nafziger . Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Int Med 2003; 163: 2014–18.
82R Holland , J Desborough , L Goodyer , S Hall , D Wright , YK Loke . Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol 2008; 65: 303–16.
83U Gillespie , A Alassaad , D Henrohn , H Garmo , M Hammarlund-Udenaes , H Toss A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Int Med 2009; 169: 894–900.
84KE Schmader , JT Hanlon , CF Pieper , R Sloane , CM Ruby , J Twersky Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004; 116: 394–401.
85F Andersohn , S Suissa , E Garbe . Use of first- and second-generation cyclooxygenase-2-selective non-steroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation 2006; 113: 1950–57.
86CR Ayers , JT Sorrell , SR Thorp , JL Wetherell . Evidence-based psychological treatments for late-life anxiety. Psychology Aging 2007; 22: 8–17.
87UA Meyer . Pharmacogenetics and adverse drug reactions. Lancet 2000; 356: 1667–71.
88CJ Ross , H Katzov , B Carleton , MR Hayden . Pharmacogenomics and its implications for autoimmune disease. J Autoimmun 2007; 28: 122–28.
89E Steyerberg . Clinical Prediction Models: A practical approach to development, validation, and updating. MKK Gail , J Samet , A Tsiatis , W Wong (eds). Rotterdam: Springer; 2009.
90JH Wasson , HC Sox , RK Neff , L Goldman . Clinical prediction rules. Applications and methodological standards. NEJM 1985; 313: 793–99.
91PE Johnston , DJ France , DW Byrne , HJ Murff , B Lee , RA Stiles Assessment of adverse drug events among patients in a tertiary care medical center. Am J Health Syst Pharm 2006; 63: 2218–27.